🇺🇸 FDA

Intelligence · Patent portfolio

NEUROCRINE BIOSCIENCES Patents

Full USPTO pharma patent portfolio for NEUROCRINE BIOSCIENCES — grant dates, expiration, and drug cross-links.

Patents
111
Expiring ≤24m
8

Quick answer

NEUROCRINE BIOSCIENCES has 111 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 8 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 3

  1. US 6485746

    Controlled-release sedative-hypnotic compositions and methods related thereto

    Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6469166

    Thiophenopyrimidines

    Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6440960

    CRF receptor antagonists and methods relating thereto

    Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6384221

    Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Expires Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6379670

    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein

    Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6369033

    Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

    Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6348466

    CRF receptor antagonists and methods relating thereto

    Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6329499

    Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein

    Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6288060

    Amino substituted pyrimidines and triazines

    Expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6255310

    Thiophenopyrimidines

    Expires Mon Jun 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6251396

    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein

    Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6239268

    Interleukin-1 type 3 receptors

    Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6211195

    CRF antagonistic thiophenopyridines

    Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6197926

    Methods for treatment of diabetes using peptide analogues of insulin

    Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6133276

    Compounds and methods for increasing endogenous levels of corticotropin-releasing factor

    Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does NEUROCRINE BIOSCIENCES have?

111 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NEUROCRINE BIOSCIENCES patents expire?

8 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.